India Molecular Diagnostics Market By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In-situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Others), By End User (Hospitals, Academic & Reference Laboratories), By Region, Competition, Forecast & Opportunities, FY 2026

September 2020 | 77 pages | ID: IE5193062ACDEN
TechSci Research

Abstracts

India molecular diagnostics market stood at an estimated $ 920 million in FY 2020 and is projected to grow at a CAGR of around 10% until FY 2026, predominantly on account of rising cases of fatal and chronic diseases. Moreover, spread of COVID-19 pandemic is expected to create more opportunities, which is anticipated to drive market growth during the forecast period. Furthermore, government initiatives of raising funds for the country’s molecular department is also expected to positively influence the market in the coming years. However, since the department requires high competence and professional skillset, absence of the same can pose a hurdle. Also, with over 25% of the country’s population being below poverty line and the rest of the population is either middle-class or lower middle-class, lack of funds and high cost of molecular diagnostics is also expected to hinder the growth of the market during the forecast period.

India molecular diagnostics market is segmented into application, technology, end user, and region. Based on application, the market is further fragmented into infectious disease, blood screening, genetic testing and oncology testing, out of which oncology testing segment is expected to dominate the market until FY 2026, followed by the infectious disease segment.

Major players operating in India molecular diagnostics market include Roche Diagnostics India Pvt Ltd, Abbott India Limited, Qiagen India Pvt Ltd, bioM?rieux India, Becton Dickinson Private Limited, Biocartis, Bio-Techne India Private Limited, Danaher, Bio-Rad laboratories India Pvt.Ltd, Cleaver Scientific, etc.

Years considered for this report:

Historical Years: FY2016 - FY2019

• Base Year: FY2020
• Estimated Year: FY2021
• Forecast Period: FY2022 - FY2026

Objective of the Study:

• To analyze and estimate the market size of India molecular diagnostics market from FY2016 to FY2020.
• To estimate and forecast the market size of India molecular diagnostics market from FY2021 to FY2026.
• To classify and forecast India molecular diagnostics market based on application, technology, end user, region and company.
• To identify dominant region or segment in the India molecular diagnostics market.
• To identify drivers and challenges for India molecular diagnostics market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India molecular diagnostics market.
• To conduct pricing analysis for India molecular diagnostics market.
• To identify and analyze the profile of leading players operating in India molecular diagnostics market.
• To identify key sustainable strategies adopted by market players in India molecular diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of India molecular diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• End users, hospitals, and laboratories
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to molecular diagnostics

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India molecular diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Market, By Application:
• Infectious disease
• Blood screening
• Genetic testing
• Oncology testing
• Market, By Technology:
• PCR
• In-situ hybridization
• Chips and microarrays
• Mass spectrometry
• Sequencing
• Others
• Market, By End User:
• Hospitals
• Academic & Reference Laboratories
• Market, By Region:

North

• East
• West
• South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India molecular diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. VOICE OF CUSTOMER

5. INDIA MOLECULAR DIAGNOSTICS MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Application (Infectious disease, Blood screening, Genetic testing, Oncology testing)
  5.2.2. By Technology (PCR, In-situ hybridization, Chips and microarrays, Mass spectrometry, Sequencing, Others)
  5.2.3. By End User (Hospitals, Academic & Reference Laboratories)
  5.2.4. By Region (North, East, West, South)
  5.2.5. By Company (FY2020)
5.3. Market Attractiveness Index

6. INDIA PCR TECHNOLOGY BASED MOLECULAR DIAGNOSTICS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Application
  6.2.2. By End User

7. INDIA IN-SITU HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Application
  7.2.2. By End User

8. INDIA CHIPS AND MICROARRAYS MOLECULAR DIAGNOSTICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Application
  8.2.2. By End User

9. INDIA MASS SPECTROMETRY MOLECULAR DIAGNOSTICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Application
  9.2.2. By End User

10. INDIA SEQUENCING MOLECULAR DIAGNOSTICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Application
  10.2.2. By Technology
  10.2.3. By End User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

13. POLICY & REGULATORY LANDSCAPE

14. INDIA ECONOMIC PROFILE

15. COMPETITIVE LANDSCAPE

15.1. Competition Outlook
15.2. Company Profiles
  15.2.1. Roche Diagnostics India Pvt Ltd
  15.2.2. Abbott India Limited
  15.2.3. Qiagen India Pvt Ltd
  15.2.4. bioM?rieux India Pvt. Ltd.
  15.2.5. Becton Dickinson Private Limited
  15.2.6. Biocartis Group
  15.2.7. Bio-Techne India Private Limited
  15.2.8. Danaher Corporation
  15.2.9. Bio-Rad laboratories India Pvt.Ltd
  15.2.10. Cleaver Scientific

16. STRATEGIC RECOMMENDATIONS

List Of Figures

LIST OF FIGURES

Figure 1: India Molecular Diagnostic Market Size, By Value (USD Million), FY2016-FY2026
Figure 2: India Molecular Diagnostic Market Share, By Product Type, FY2016-FY2026
Figure 3: India Molecular Diagnostic Market Size, By PCR, FY2016-FY2026
Figure 4: India Molecular Diagnostic Market Size, By Mass Spectrophotometer, FY2016-FY2026
Figure 5: India Molecular Diagnostic Market Size, By Sequencing, FY2016-FY2026
Figure 6: India Molecular Diagnostic Market Size, By Others, FY2016-FY2026
Figure 7: India Molecular Diagnostic Market Share, By Technology, FY2016-FY2026
Figure 8: India Molecular Diagnostic Market Share, By Application, FY2016-FY2026
Figure 9: India Molecular Diagnostic Market Share, By End-User, FY2016-FY2026
Figure 10: India Molecular Diagnostic Market Share, By Company, FY2016-FY2026
Figure 11: India Molecular Diagnostic Market Share, By Region, FY2016-FY2026
Figure 12: India Molecular Diagnostic Market Share Attractiveness Index, By Type, By Value, FY2016-FY2026F

COMPANIES MENTIONED

1.Roche Diagnostics India Pvt Ltd
2.Abbott India Limited
3.Qiagen India Pvt Ltd
4.bioM?rieux India Pvt. Ltd.
5.Becton Dickinson Private Limited
6.Biocartis Group
7.Bio-Techne India Private Limited
8.Danaher Corporation
9.Bio-Rad laboratories India Pvt.Ltd
10.Cleaver Scientific